Loading clinical trials...
Loading clinical trials...
Sleep Quality, Cognitive Performance, and Computerized Cognitive Training Comparison of Patients Treated With Lurasidone vs.Patients With Major Depression Receiving Selective Serotonin Reuptake Inhibitor(SSRI) Treatment as Usual
Conditions
Interventions
Lurasidone
FDA Approved antidepressant treatment
Locations
1
United States
George West Mental Health Foundation, DBA Skyland Trail
Atlanta, Georgia, United States
Start Date
April 15, 2024
Primary Completion Date
January 22, 2025
Completion Date
January 22, 2025
Last Updated
May 4, 2025
NCT07140913
NCT07523048
NCT07172516
NCT07226661
NCT07115329
NCT07226895
Lead Sponsor
George West Mental Health Foundation d/b/a Skyland Trail
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions